Citadel Advisors - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 16 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$29,576,000
+1.8%
19,655,0000.0%0.04%
+15.6%
Q4 2015$29,054,000
-14.4%
19,655,000
-9.2%
0.03%0.0%
Q3 2015$33,955,000
-38.2%
21,655,000
-17.2%
0.03%
-33.3%
Q2 2015$54,923,000
-14.9%
26,155,000
-18.7%
0.05%
-21.3%
Q1 2015$64,537,000
+1.2%
32,155,000
-4.5%
0.06%
-3.2%
Q4 2014$63,761,000
+21.6%
33,655,0000.0%0.06%
+14.5%
Q3 2014$52,453,000
+57.4%
33,655,000
+36.5%
0.06%
+44.7%
Q2 2014$33,331,000
+64.5%
24,650,000
+23.2%
0.04%
+58.3%
Q1 2014$20,265,000
+114.8%
20,000,000
+122.2%
0.02%
+100.0%
Q4 2013$9,433,000
+15.9%
9,000,0000.0%0.01%0.0%
Q3 2013$8,138,0009,000,0000.01%
Other shareholders

There were no reported owners of MERRIMACK PHARMACEUTICALS IN in Q4 2014.

NameSharesValueWeighting ↓
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders